RxDoctor Payments Data

Valerie Watts

Family · Saint Joseph, MONPI 1962893263

Payments from drug & device makers

$2,145in general payments, 2019–2025

Across 107 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$412
  • AbbVie$351
  • AstraZeneca$303
  • Lilly USA, LLC$191
  • Astellas Pharma US Inc$153
  • Amgen$118
  • plus $616 from 13 others

What the payments were for

  • Food & beverage$2,05596%
  • Education$904%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,145 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$34,490
Medicare patients
133
Services billed
714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin14$14,286
Atorvastatin Calcium72$679
Gabapentin28$642
Fluticasone Propionate21$601
Bupropion XlBupropion Hcl14$456
Alendronate Sodium25$324
Albuterol Sulfate HfaAlbuterol Sulfate11$322
Losartan Potassium41$311
Duloxetine Hcl14$289
Pantoprazole Sodium27$245
Sertraline Hcl20$231
Montelukast Sodium16$207
Meloxicam32$181
Potassium Chloride17$175
Metformin Hcl ErMetformin Hcl27$160

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$18$14,28614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Saint Joseph

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →